Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2021 call → NOWe need to determine if the company is currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event that ends the wait, and management conveys this as a present-tense reality. Let's examine the transcript for evidence. Key points from the call: - John Fortson mentions: "We completed alternative fatty acid production and saw the first sales of our new ALTAVEG product. We continue to assess other feedstocks and expect commercial sales to grow this year." That's about alternative fatty acids, but not necessarily a waiting period. - Mike Smith: "We also sold non-CTO based alternative fatty acids as well as alternative fatty acid derivatives in Q4. We remain excited about the additional alternative fatty acid capacity at our Crossett facility coming online in early Q2 of this year to support more substantial future sales growth." This indicates a facility coming online in early Q2, which is near-dated. But is the company currently paying for it? They are building it, but the transcript doesn't explicitly say they are incurring costs now for something not yet earning. However, they mention "additional capacity" coming online, which implies they are investing in it. But is it a "waiting period" they are paying for? They already have some sales of ALTAVEG, so it's not entirely waiting. - John Fortson: "We will continue to invest organically, as we bring online our new polyol capability in DeRidder and an alternate fatty acid stream in Crossett." This is about bringing online new capabilities. They are investing, but are they currently paying for something not yet earning? The new polyol capability in DeRidder is mentioned as coming online in the middle of this year (from Mike Smith's comment: "we're very much looking forward to getting the start-up of our new polyol facility in DeRidder here in the middle of this year."). So that is a specific near-dated event. But is the company currently bearing costs for it? They are building it, so yes, they are paying for construction, but the transcript doesn't explicitly say they are incurring costs now that are hitting results. However, they mention "CapEx will be elevated somewhat from recent levels" and they are investing in these projects.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.